Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Testicular relapse in adult acute myelogenous leukemia.
Shaffer DW, Burris HA, O'Rourke TJ. Shaffer DW, et al. Among authors: burris ha. Cancer. 1992 Sep 15;70(6):1541-4. doi: 10.1002/1097-0142(19920915)70:6<1541::aid-cncr2820700616>3.0.co;2-6. Cancer. 1992. PMID: 1516005 Review.
New anticancer agents.
Brown TD, Burris HA, Eckardt JR, O'Rourke TJ, Rodriguez GI, Wall JG, Weiss GR. Brown TD, et al. Among authors: burris ha. Cancer Chemother Biol Response Modif. 1992;13:115-55. Cancer Chemother Biol Response Modif. 1992. PMID: 1389907 Review. No abstract available.
New anticancer agents.
Brown TD, Burris HA, Havlin KA, O'Rourke TJ, Rodriguez GI, Wall JG, Weiss GR. Brown TD, et al. Among authors: burris ha. Cancer Chemother Biol Response Modif. 1991;12:111-46. Cancer Chemother Biol Response Modif. 1991. PMID: 1718374 Review. No abstract available.
New anticancer agents.
Weiss GR, Burris HA 3rd, Eckardt JR, Fields S, O'Rourke T, Rodriguez GI, Rothenberg ML. Weiss GR, et al. Among authors: burris ha 3rd. Cancer Chemother Biol Response Modif. 1994;15:130-51. Cancer Chemother Biol Response Modif. 1994. PMID: 7779583 Review. No abstract available.
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812).
O'Rourke TJ, Weiss GR, New P, Burris HA 3rd, Rodriguez G, Eckhardt J, Hardy J, Kuhn JG, Fields S, Clark GM, et al. O'Rourke TJ, et al. Among authors: burris ha 3rd. Anticancer Drugs. 1994 Oct;5(5):520-6. doi: 10.1097/00001813-199410000-00002. Anticancer Drugs. 1994. PMID: 7858283 Clinical Trial.
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule.
Brown TD, O'Rourke TJ, Kuhn JG, Craig JB, Havlin K, Burris HA 3rd, Cagnola J, Hamilton JM, Grindey GB, Satterlee WG, et al. Brown TD, et al. Among authors: burris ha 3rd. Anticancer Drugs. 1994 Apr;5(2):151-9. doi: 10.1097/00001813-199404000-00005. Anticancer Drugs. 1994. PMID: 8049498 Clinical Trial.
436 results